These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29479888)

  • 61. Down-regulation of MicroRNA-592 in obesity contributes to hyperglycemia and insulin resistance.
    Song Y; Wu L; Li M; Xiong X; Fang Z; Zhou J; Yan G; Chen X; Yang J; Li Y
    EBioMedicine; 2019 Apr; 42():494-503. PubMed ID: 30948354
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Serum R-Spondin 1 Is a New Surrogate Marker for Obesity and Insulin Resistance.
    Kang YE; Kim JM; Yi HS; Joung KH; Lee JH; Kim HJ; Ku BJ
    Diabetes Metab J; 2019 Jun; 43(3):368-376. PubMed ID: 30398036
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes.
    Utzschneider KM; Van de Lagemaat A; Faulenbach MV; Goedecke JH; Carr DB; Boyko EJ; Fujimoto WY; Kahn SE
    Obesity (Silver Spring); 2010 Sep; 18(9):1781-7. PubMed ID: 20379148
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Oral glucose tolerance test unravels circulating miRNAs associated with insulin resistance in obese preschoolers.
    Masotti A; Baldassarre A; Fabrizi M; Olivero G; Loreti MC; Giammaria P; Veronelli P; Graziani MP; Manco M
    Pediatr Obes; 2017 Jun; 12(3):229-238. PubMed ID: 27059430
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.
    Salvoza NC; Klinzing DC; Gopez-Cervantes J; Baclig MO
    PLoS One; 2016; 11(4):e0153497. PubMed ID: 27077736
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Serum visfatin, resistin and IL-18 in A group of Egyptian obese diabetic and non diabetic individuals.
    Mabrouk R; Ghareeb H; Shehab A; Omar K; El-Kabarity RH; Soliman DA; Mohamed NA
    Egypt J Immunol; 2013; 20(1):1-11. PubMed ID: 23888552
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dysregulated miR-103 and miR-143 expression in peripheral blood mononuclear cells from induced prediabetes and type 2 diabetes rats.
    Vatandoost N; Amini M; Iraj B; Momenzadeh S; Salehi R
    Gene; 2015 Nov; 572(1):95-100. PubMed ID: 26164754
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Circulating serum irisin levels in obesity and type 2 diabetes mellitus.
    Shoukry A; Shalaby SM; El-Arabi Bdeer S; Mahmoud AA; Mousa MM; Khalifa A
    IUBMB Life; 2016 Jul; 68(7):544-56. PubMed ID: 27220658
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tumor necrosis factor alpha -238G>A genotype alters postprandial plasma levels of free fatty acids in obese individuals with type 2 diabetes mellitus.
    Fontaine-Bisson B; Wolever TM; Chiasson JL; Rabasa-Lhoret R; Maheux P; Josse RG; Leiter LA; Rodger NW; Ryan EA; El-Sohemy A
    Metabolism; 2007 May; 56(5):649-55. PubMed ID: 17445540
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Circulating miR-143-3p inhibition protects against insulin resistance in Metabolic Syndrome via targeting of the insulin-like growth factor 2 receptor.
    Xihua L; Shengjie T; Weiwei G; Matro E; Tingting T; Lin L; Fang W; Jiaqiang Z; Fenping Z; Hong L
    Transl Res; 2019 Mar; 205():33-43. PubMed ID: 30392876
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control.
    Santovito D; De Nardis V; Marcantonio P; Mandolini C; Paganelli C; Vitale E; Buttitta F; Bucci M; Mezzetti A; Consoli A; Cipollone F
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1681-5. PubMed ID: 24937531
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Associations of the Inflammatory Marker YKL-40 with Measures of Obesity and Dyslipidaemia in Individuals at High Risk of Type 2 Diabetes.
    Thomsen SB; Gjesing AP; Rathcke CN; Ekstrøm CT; Eiberg H; Hansen T; Pedersen O; Vestergaard H
    PLoS One; 2015; 10(7):e0133672. PubMed ID: 26197239
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Acute hyperinsulinemia decreases plasma osteoprotegerin with diminished effect in type 2 diabetes and obesity.
    Jørgensen GM; Vind B; Nybo M; Rasmussen LM; Højlund K
    Eur J Endocrinol; 2009 Jul; 161(1):95-101. PubMed ID: 19380455
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Acute hyperinsulinemia differentially regulates interstitial and circulating adiponectin oligomeric pattern in lean and insulin-resistant, obese individuals.
    Murdolo G; Hammarstedt A; Schmelz M; Jansson PA; Smith U
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4508-16. PubMed ID: 19820029
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Haptoglobin serum levels are independently associated with insulinemia in overweight and obese women.
    De Pergola G; Di Roma P; Paoli G; Guida P; Pannacciulli N; Giorgino R
    J Endocrinol Invest; 2007 May; 30(5):399-403. PubMed ID: 17598972
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Altered circulatory levels of miR-128, BDNF, cortisol and shortened telomeres in patients with type 2 diabetes and depression.
    Prabu P; Poongothai S; Shanthirani CS; Anjana RM; Mohan V; Balasubramanyam M
    Acta Diabetol; 2020 Jul; 57(7):799-807. PubMed ID: 32025863
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Roles of microRNA-221/222 in type 2 diabetic patients with post-menopausal breast cancer.
    Li MY; Pan SR; Qiu AY
    Genet Mol Res; 2016 Jul; 15(2):. PubMed ID: 27420990
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Failure of hyperglycemia and hyperinsulinemia to compensate for impaired metabolic response to an oral glucose load.
    Hussain M; Janghorbani M; Schuette S; Considine RV; Chisholm RL; Mather KJ
    J Diabetes Complications; 2015 Mar; 29(2):238-44. PubMed ID: 25511878
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fetuin-A levels are increased in the adipose tissue of diabetic obese humans but not in circulation.
    Khadir A; Kavalakatt S; Madhu D; Hammad M; Devarajan S; Tuomilehto J; Tiss A
    Lipids Health Dis; 2018 Dec; 17(1):291. PubMed ID: 30579336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.